Endurant Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,017
Closed -$286K 21
2023
Q4
$286K Sell
20,017
-183,775
-90% -$2.61M 1.64% 19
2023
Q3
$2.84M Buy
+203,792
New +$2.61M 2.55% 13
2023
Q2
Sell
-1,165,923
Closed -$13.4M 56
2023
Q1
$13.4M Buy
1,165,923
+729,399
+167% +$9.02M 6.89% 4
2022
Q4
$5.43M Buy
+436,524
New +$5.57M 2.2% 11
2018
Q3
Sell
-90,922
Closed -$1.98M 83
2018
Q2
$1.98M Sell
90,922
-194,297
-68% -$3.79M 0.86% 31
2018
Q1
$5.03M Sell
285,219
-349,200
-55% -$6.16M 1.88% 18
2017
Q4
$11.9M Buy
634,419
+78,089
+14% +$1.55M 3.64% 4
2017
Q3
$12.2M Buy
+556,330
New +$12.6M 3.7% 4

Other funds holding SBRA

Endurant Capital Management's SBRA Position: Q1 2024 in Review

Endurant Capital Management sold out of Sabra Healthcare REIT (SBRA) in Q1 2024, closing a stake of 20,017 shares — an estimated $286K sold.

Endurant Capital Management first reported a position in SBRA in Q3 2017 and held it in 8 quarters. The position peaked at $13.4M in Q1 2023. 342 funds tracked by Wall St. Rank hold SBRA as of Q1 2024.

  • Endurant Capital Management reported no remaining Sabra Healthcare REIT position as of Q1 2024 after selling out during the quarter.
  • Endurant Capital Management sold 20,017 Sabra Healthcare REIT shares in Q1 2024, an estimated $286K.
  • Endurant Capital Management first reported a position in Sabra Healthcare REIT in Q3 2017 and held it in 8 quarters.
  • Endurant Capital Management's Sabra Healthcare REIT position peaked at $13.4M in Q1 2023.
  • 342 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2024.

Based on Endurant Capital Management's 13F filing for Q1 2024.